UP Health System Marquette Medication Guideline High Alert Drugs
|
|
|
- Adam Carroll
- 6 years ago
- Views:
Transcription
1 1 ALTEPLASE SOLR 100 MG ACTIVASE TRUE ALTEPLASE SOLR 50 MG ACTIVASE TRUE AMIODARONE INJ 50 MG/ML CORDARONE IV TRUE AMIODARONE INJ 50 MG/ML CORDARONE IV TRUE AMIODARONE SYRG 150 MG/3 ML CORDARONE TRUE AMIODARONE 1500MCG/ML SYRG 1500MCG/ML CORDARONE TRUE AMIODARONE IN DEXTROSE 5% SOLN 450 MG/250 ML (1.8 MG/ML) AMIODARONE IN DEXTROSE 5% TRUE AMIODARONE IN DEXTROSE,ISO-OSM PGBK 150 MG/100 ML (1.5 MG/ML) NEXTERONE TRUE AMIODARONE IN DEXTROSE,ISO-OSM SOLN 360 MG/200 ML (1.8 MG/ML) NEXTERONE TRUE AMPHOTERICIN B LIPOSOME SUSR 50 MG AMBISOME TRUE ANASTROZOLE TAB 1 MG ARIMIDEX TRUE APIXABAN TAB 2.5 MG ELIQUIS TRUE APIXABAN TAB 5 MG ELIQUIS TRUE ARGATROBAN INJ 100 MG/ML ARGATROBAN TRUE BEVACIZUMAB INJ 25 MG/ML AVASTIN TRUE BEVACIZUMAB INJ 25 MG/ML AVASTIN TRUE BICALUTAMIDE TAB 50 MG CASODEX TRUE BIVALIRUDIN INJ 250 MG ANGIOMAX TRUE BORTEZOMIB INJ 3.5 MG VELCADE TRUE CALCIUM CHLORIDE INJ 10 % CALCIUM CHLORIDE TRUE CALCIUM CHLORIDE SYRG 10 % (100 MG/ML) CALCIUM CHLORIDE TRUE CALCIUM GLUCONATE 50MG/ML INJ SYRG 50MG/ML CALCIUM GLUCONATE 50MG/ML INJ TRUE CARBOplatin INJ 10 MG/ML PARAPLATIN TRUE CARBOplatin INJ 10 MG/ML PARAPLATIN TRUE CARMUSTINE IN POLIFEPROSAN WAFR 7.7 MG GLIADEL WAFER TRUE CISATRACURIUM INJ 2 MG/ML NIMBEX TRUE CISplatin INJ 1 MG/ML PLATINOL TRUE CLINIMIX **E** / DEXTROSE 10% SOLP 4.25 % CLINIMIX E 4.25/D10 SULFITFREE TRUE CLINIMIX / DEXTROSE 10% SOLP 4.25 % CLINIMIX 4.25/D10 SULFITE FREE TRUE CYCLOPHOSPHAMIDE INJ 1000 MG CYTOXAN TRUE CYCLOPHOSPHAMIDE INJ 500 MG CYTOXAN TRUE CYCLOPHOSPHAMIDE TAB 25 MG CYTOXAN TRUE CYTARABINE INJ 100 MG CYTARABINE TRUE CYTARABINE-PF INJ 2 GM/20 ML (100 MG/ML) CYTARABINE (PF) TRUE D70 500ML SOLP DEXTROSE 70% IN WATER (D70W) TRUE D70W 2000ML SOLP DEXTROSE 70 % IN WATER (D70W) TRUE DABIGATRAN ETEXILATE CAP 150 MG PRADAXA TRUE DAUNOrubicin INJ 20 MG CERUBIDINE TRUE DEXMEDETOMIDINE INJ 100 MCG/ML PRECEDEX TRUE DEXMEDETOMIDINE / NS 50ML INJ 4MCG/ML PRECEDEX TRUE
2 2 DEXTROSE 25% IN WATER SYRG DEXTROSE 25% IN WATER (D25W) TRUE DEXTROSE 50% IN WATER SYRG DEXTROSE 50% IN WATER (D50W) TRUE DIGOXIN INJ 100 MCG/ML LANOXIN PEDIATRIC TRUE DIGOXIN INJ 250 MCG/ML LANOXIN TRUE DIGOXIN 10MCG/ML SYRG 10MCG/ML LANOXIN TRUE DOCETAXEL INJ 20 MG / 1 ML TAXOTERE TRUE DOCETAXEL INJ 80MG/4ML TAXOTERE TRUE DOXOrubicin INJ 10 MG/5 ML ADRIAMYCIN TRUE DOXOrubicin INJ 50 MG/ 25 ML ADRIAMYCIN TRUE ENOXAPARIN SYRG 100 MG/ML LOVENOX TRUE ENOXAPARIN SYRG 30 MG/0.3 ML LOVENOX TRUE ENOXAPARIN SYRG 40 MG/0.4 ML LOVENOX TRUE ENOXAPARIN SYRG 60 MG/0.6 ML LOVENOX TRUE ENOXAPARIN SYRG 80 MG/0.8 ML LOVENOX TRUE EPINEPHrine INJ 1 MG/ML EPINEPHRINE TRUE EPINEPHrine INJ 1 MG/ML EPINEPHRINE TRUE EPINEPHRINE 24MCG/ML SYRG 24MCG/ML EPINEPHRINE TRUE EPINEPHRINE 64MCG/ML SYRG 64MCG/ML EPINEPHRINE TRUE EPINEPHrine HCL 1 1/2 SYRG 0.1 MG/ML EPINEPHRINE HCL TRUE EPIRUBICIN INJ 50 MG EPIRUBICIN TRUE EPOPROSTENOL SODIUM INJ 0.5 MG VELETRI TRUE EPTIFIBATIDE INJ 0.75 MG/ML INTEGRILIN TRUE EPTIFIBATIDE INJ 2 MG/ML INTEGRILIN TRUE ETOPOSIDE INJ 20 MG/ML TOPOSAR TRUE FENTanyl 100MCG/HR PT MCG/HR DURAGESIC TRUE FENTanyl 12MCG/HR PT72 12 MCG/HR DURAGESIC TRUE FENTanyl 25MCG/HR PT72 25 MCG/HR DURAGESIC TRUE FENTanyl 50MCG/HR PT72 50 MCG/HR DURAGESIC TRUE FENTANYL CITRATE -PF INJ 50 MCG/ML SUBLIMAZE (P/F) TRUE FENTanyl CITRATE -PF INJ 50 MCG/ML SUBLIMAZE (P/F) TRUE FENTanyl CITRATE -PF INJ 50 MCG/ML SUBLIMAZE (P/F) TRUE FENTANYL-BUPIVACAINE-NACL-PF SOLN MCG/ML-% SUBLIMAZE BUPIVACAINE-NACL PF TRUE FLUOROURACIL INJ 500 MG/10 ML ADRUCIL TRUE GEMCITABINE INJ 1 GM GEMZAR TRUE GEMCITABINE INJ 200 MG GEMZAR TRUE HEPARIN - PF SYRG 5,000 UNIT/0.5 ML HEPARIN, PORCINE (PF) TRUE HEPARIN 1 UNIT/ 1 ML 0.9% NS-PF INJ SYRG 1UNIT/ML HEPARIN 1 UNIT/1 ML NS INJ TRUE HEPARIN 1,000 units/ml INJ 1,000 UNIT/ML HEPARIN (PORCINE) TRUE HEPARIN 10,000 units/ml INJ 10,000 UNIT/ML HEPARIN (PORCINE) TRUE HEPARIN IN D5W SOLP 25,000 UNIT/500 ML (50 UNIT/ML HEPARIN (PORCINE) IN D5W TRUE
3 3 HEPARIN IN NS -PF SOLP 1,000 UNIT/500 ML HEPARIN (PORCINE) IN NS (PF) TRUE HEPARIN LOCK FLUSH SYRG 100 UNIT/ML HEP-LOCK FLUSH TRUE HEPARIN LOCK FLUSH SYRG 100 UNIT/ML HEPARIN LOCK FLUSH (PORCINE) TRUE HYDROXYUREA CAP 500 MG HYDREA TRUE IDArubicin INJ 1 MG/ML IDAMYCIN PFS TRUE IDArubicin INJ 1 MG/ML IDAMYCIN PFS TRUE IFOSFAMIDE INJ 1 GM IFEX TRUE INSULIN 70/30 INJ 100 UNIT/ML (70-30) HUMULIN 70/ TRUE INSULIN ASPART 100 UNIT/ML INPN 100 UNIT/ML NOVOLOG FLEXPEN TRUE INSULIN DETEMIR INPN 100 UNIT/ML (3 ML) LEVEMIR FLEXPEN TRUE INSULIN GLARGINE INPN 300 UNIT/3 ML LANTUS SOLOSTAR TRUE INSULIN LISPRO PROTAM LISPRO INJ 100 UNIT/ML (75-25) HUMALOG MIX TRUE INSULIN NPH RECOMB INJ 100 UNIT/ML HUMULIN N TRUE INSULIN R 0.1UNIT/ML SYRG 0.1UNIT/ML INSULIN R TRUE INSULIN R 1UNIT/ML SYRG 1UNIT/ML INSULIN R TRUE INSULIN REGULAR 100 UNIT/ML INJ 100 UNIT/ML HUMULIN R TRUE IRINOTECAN INJ 100 MG/5 ML CAMPTOSAR TRUE KETAMINE INJ 200 MG/20 ML KETALAR TRUE KETAMINE INJ 500 MG/10 ML KETALAR TRUE KETAMINE INJ 500 MG/5 ML KETALAR TRUE KETAMINE SYRG 50 MG/5 ML (10 MG/ML) KETAMINE IN 0.9% NACL TRUE LABETALOL INJ 5 MG/ML NORMODYNE TRUE LABETALOL SYRG 20 MG/4 ML (5 MG/ML) LABETALOL TRUE LETROZOLE TAB 2.5 MG FEMARA TRUE LEUPROLIDE SYRG 7.5 MG LUPRON DEPOT TRUE LIDOCAINE (MPF) 2% INJ 20 MG/ML (2 %) LIDOCAINE (PF) TRUE LIDOCAINE 1% -PF INJ 10 MG/ML (1 %) LIDOCAINE (PF) TRUE LIDOCAINE ABBO 1% 5ML SYRG 10 MG/ML (1 %) LIDOCAINE (PF) TRUE LIDOCAINE ABBO 2% 5ML SYRG 20 MG/ML (2 %) LIDOCAINE (PF) TRUE LIDOCAINE HCL 2% INJ 20 MG/ML (2 %) LIDOCAINE HCL TRUE LIDOCAINE IN D5W -PF SOLP 4 MG/ML (0.4 %) LIDOCAINE IN D5W (PF) TRUE LIDOCAINE -PF INJ 20 MG/ML (2 %) LIDOCAINE (PF) TRUE LIDOCAINE -PF INJ 40 MG/ML (4 %) LIDOCAINE (PF) TRUE LIDOCAINE -PF INJ 5 MG/ML (0.5 %) XYLOCAINE-MPF TRUE MAGNESIUM SULFATE INJ 50 % (4 MEQ/ML) MAGNESIUM SULFATE TRUE MAGNESIUM SULFATE INJ 500MG/ML MAGNESIUM SULFATE TRUE MEGESTROL SUSP 400 MG/10 ML MEGACE TRUE MEGESTROL TAB 40 MG MEGACE TRUE METHadone INJ 10 MG/ML METHADONE TRUE METHadone TAB 10 MG DOLOPHINE TRUE
4 4 METHadone TAB 5 MG DOLOPHINE TRUE METHadone 5 MG/5 ML SOLN 5 MG/5 ML METHADONE TRUE METHOTREXATE 1000MG INJ 25 MG/ML METHOTREXATE SODIUM (PF) TRUE METHOTREXATE 250MG INJ 25 MG/ML METHOTREXATE NA (PRESERV FREE) TRUE METHOTREXATE 50MG/2ML INJ 25 MG/ML METHOTREXATE SODIUM (PF) TRUE METHOTREXATE SODIUM TAB 2.5 MG METHOTREXATE SODIUM TRUE METOPROLOL TARTRATE INJ 5 MG/5 ML LOPRESSOR TRUE MIDAZOLAM INJ 1 MG/ML VERSED TRUE MIDAZOLAM INJ 5 MG/ML VERSED TRUE MIDAZOLAM INJ 5MG/1ML VERSED TRUE MIDAZOLAM 1 MG/ML INJ 1 MG/ML VERSED TRUE MIDAZOLAM 5 MG/ML INJ 5 MG/ML VERSED TRUE MIDAZOLAM 500MCG/ML SYRG 500MCG/ML MIDAZOLAM TRUE MIDAZOLAM IN 0.9 % NACL SOLN 1 MG/ML MIDAZOLAM IN 0.9 % NACL TRUE MILRINONE INJ 1 MG/ML PRIMACOR TRUE mitomycin INJ 20 MG MUTAMYCIN TRUE MITOMYCIN INJ 5 MG MUTAMYCIN TRUE MORPHINE IR TAB 15 MG MSIR TRUE NITROPRUSSIDE INJ 25 MG/ML NITROPRESS TRUE NOREPINEPHRINE BITARTRATE INJ 1 MG/ML LEVOPHED BITARTATE TRUE NOREPINEPHRINE IN NS SOLP 4MG/250ML NOREPINEPHRINE IN NS TRUE OXALIPLATIN INJ 100 MG/20 ML ELOXATIN TRUE OXALIPLATIN INJ 50 MG/10 ML (5 MG/ML) ELOXATIN TRUE oxycodone CONC 20 MG/ML ROXICODONE INTENSOL TRUE oxycodone SOLN 5 MG/5 ML ROXICODONE TRUE oxycodone TAB 15 MG ROXICODONE TRUE oxycodone TAB 5 MG ROXICODONE TRUE oxycodone TB12 10 MG OXYCONTIN TRUE oxycodone TB12 20 MG OXYCONTIN TRUE oxycodone TB12 40 MG OXYCONTIN TRUE PANCURONIUM INJ 2 MG/ML PANCURONIUM TRUE PHENYLEPHRINE (ANES) SYRG 1 MG/10 ML (100 MCG/ML) PHENYLEPHRINE IN 0.9% NACL(PF) TRUE PHENYLEPHRINE HCL INJ 10 MG/ML VAZCULEP TRUE PHENYLEPHRINE IN NS 20MG/250 ML SOLN 20 MG/250 ML (80 MCG/ML) NEO-SYNEPHRINE TRUE PHENYLEPHRINE SYRINGE SYRG 250 MCG NEO-SYNEPHRINE TRUE POTASSIUM CHLORIDE INJ 2 MEQ/ML KCL 20MEQ TRUE POTASSIUM CHLORIDE INJ 2 MEQ/ML KCL 40MEQ TRUE PROMETHAZINE INJ 25 MG/ML PHENERGAN TRUE PROPOFOL EMUL 10 MG/ML DIPRIVAN TRUE PROPOFOL DRIP EMUL 10 MG/ML DIPRIVAN TRUE
5 5 PROPRANOLOL INJ 1 MG/ML INDERAL TRUE RANITIDINE HCL INJ 25 MG/ML ZANTAC TRUE rituximab CONC 10 MG/ML RITUXAN TRUE rituximab CONC 10 MG/ML RITUXAN TRUE RIVAROXABAN TAB 15 MG XARELTO TRUE RIVAROXABAN TAB 20 MG XARELTO TRUE ROCURONIUM INJ 10 MG/ML ZEMURON TRUE SODIUM CHLORIDE INJ 4 MEQ/ML SODIUM CHLORIDE TRUE SODIUM CHLORIDE 2.5MEQ/ML SOLP 2.5 MEQ/ML SODIUM CHLORIDE TRUE SODIUM CHLORIDE 3 % SOLP 3 % SODIUM CHLORIDE 3 % TRUE SUCCINYLCHOLINE CHLORIDE INJ 20 MG/ML ANECTINE TRUE SUFENTANIL CITRATE INJ 50 MCG/ML SUFENTA TRUE SUfentanil CITRATE INJ 50 MCG/ML SUFENTA TRUE THIOGUANINE TAB 40 MG TABLOID TRUE VECURONIUM BROMIDE INJ 20 MG NORCURON TRUE VINcrisTINE INJ 1 MG/ML VINCASAR PFS TRUE VINORELBINE INJ 10 MG/ML NAVELBINE TRUE VINORELBINE INJ 50 MG/5 ML NAVELBINE TRUE WARFARIN TAB 1 MG COUMADIN TRUE WARFARIN TAB 10 MG COUMADIN TRUE WARFARIN TAB 2 MG COUMADIN TRUE WARFARIN TAB 2.5 MG COUMADIN TRUE WARFARIN TAB 5 MG COUMADIN TRUE WARFARIN TAB 7.5 MG COUMADIN TRUE WATER FOR INJECTION, STERILE INJ WATER FOR INJECTION, STERILE TRUE WATER FOR INJECTION, STERILE INJ WATER FOR INJECTION, STERILE TRUE WATER FOR INJECTION, STERILE SOLP WATER FOR INJECTION, STERILE TRUE WATER FOR IRRIGATION, STERILE SOLN WATER FOR IRRIGATION, STERILE TRUE WATER FOR IRRIGATION, STERILE SOLN WATER FOR IRRIGATION, STERILE TRUE
1 ( concentrated electrolytes ) ก
ก ก HAD 1 ( concentrated electrolytes ) ก ก ก ( ) ก ก ก ก 2 ก ก ก (Patient care unit) ก ก ก ก ( Hemodialysis ) ก ก ก ก ก ก stock card ก ก ( High Alert Drug (HAD)) ก ก ก ก (Pharmacy and Therapeutic Committee
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies:
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Incidence: The incidence of acute and delayed N&V was investigated in highly and moderately emetogenic
Don't forget to see our PharmaTags: Sterile Medication Labels at
PharmaTags: Anaesthesia Roll Labels Order Form Toll Free: 1 888 299 2661 PRICING: 10 Rolls Same Medication Label=$5.75/Roll or $57.50 Box Mix and Match 10 Rolls= $6.25/Roll or $62.50/Box Minimum Order
To help doctors give their patients the best possible care, the American
Patient Information Resources from ASCO What to Know ASCO s Guideline on Preventing Vomiting Caused by Cancer Treatment SEPTEMBER 2011 KEY MESSAGES The risk of nausea and vomiting depends on the specific
Adult Critical Care Intravenous Infusions Titration Protocol
Adult Critical Care Intravenous Infusions Protocol Nursing staff to titrate drip to achieve goal ordered by provider in assigned time intervals. Amiodarone (Pacerone ) Argatroban Non-heparin anticoagulant
HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1
drug and administration compendia Current Price () J7506 Prednisone, oral, per 5 mg 12/1/07 $0.07 $0.19 N/A prednisone 2 J8520 capecitabine (Xeloda) 1 Capecitabine, oral, 150 mg 8/1/07 $5.79 $4.59 N/A
Critical Care Standard Infusion Concentrations
Acetylcisteine (NAC) Actrapid - Human Insulin Addiphos 20mmol Addiphos 40mmol Adrenaline (Epinephrine) vs peripheral 10 g in 50mL 200mg per ml 50 units in 50mL 1 unit per ml sodium chloride 20 mmol in
LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT
LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT The following medications may be covered under your medical benefit if they are provided to you in your doctor s office or outpatient infusion
Customer Service: Shop online at
Effective May 1, 2017 Item Number Changes for Pharmaceuticals Due to changes in regulatory requirements, effective May 1, 2017, some of our pharmaceuticals' units of sale will change. The table below outlines
Medication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC
Medication Review Cancer Chemotherapy Drugs Pharmacy Technician Training Systems Passassured, LLC Medication Review, Cancer Chemotherapy Drugs PassAssured's Pharmacy Technician Training Program Medication
Drug Name Tier Drug Name Tier
Drug Name Tier Drug Name Tier ABELCET 100 MG/20 ML VIAL 4 ACETYLCYSTEINE 10% VIAL 2 ACETYLCYSTEINE 20% VIAL 2 ACYCLOVIR 1,000 MG/20 ML VIAL 2 ACYCLOVIR 500 MG/10 ML VIAL 2 ADRUCIL 500 MG/10 ML VIAL 2 ALBUTEROL
Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes
Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes Where positive identification meets safe, efficient patient care. Improve Patient Safety with Accurate Medication Labeling
Ovarian Cancer. compendia TREATMENT OF
drug & compendia TREATMENT OF Ovarian Cancer With each publication, ManagedCare Oncology s drug & Compendia highlights a single medication or a group of medications that could be utilized in the management
Form 2023 R2.0: Ovarian Cancer Pre-HSCT Data
Key Fields Sequence Number Date Received: - - CIBMTR Center Number: CIBMTR Recipient ID: Today's Date: - - Date of HSCT for which this form is being completed: - - HSCT type: (check all that apply) Autologous
Acute Lymphocytic Leukemia
Acute Lymphocytic Leukemia Splenectomy (Removal of Spleen) 6-Mercaptopurine (Purinethol, 6-MP) Alemtuzumab (Campath ) Arsenic Trioxide (Trisenox ) Bendamustine (Treanda ) Bexarotene (Targretin ) Bleomycin
Formulary Chemotherapy Agents: (Current as of 6/2018) Therapeutic Class
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Cancer LAST REVIEW 9/11/18 THERAPEUTIC CLASS Oncology REVIEW HISTORY 5/17, 5/16 LOB AFFECTED Medi-Cal (MONTH/YEAR) This policy
Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations
Conflict of Interest Declaration High Risk Medications in the Hospital Pharmacy None to disclose Monika Gil, Pharm.D. Clinical Staff Pharmacist Rush University Medical Center Chicago, IL Learning Objectives
Our mission is better health care outcomes.
Our mission is better health care outcomes. Purity Product Catalog December 2018 nephronpharm.com 1 (844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic respiratory and
Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019
5-Fluorouracil 5-FU, Fluorouracil Stability Indicating HPLC-UV USP 7-keto DHEA Stability Indicating HPLC-UV Medisca Tier 1 Acetaminophen Stability Indicating HPLC-UV USP Adenosine Alprostadil PGE-1, Prostaglandin
Look-Alike/Sound-Alike (LASA) Medication Chart
Look-Alike/Sound-Alike (LASA) Medication Chart Last Revised: August 2018 Lipid based amphotericin products amphotericin B lipid complex (Abelcet ) amphotericin B liposomal (Ambisome ) Conventional forms
Our mission is better health care outcomes.
Our mission is better health care outcomes. Efficiency Purity Efficacy Product Catalog March 2019 nephronpharm.com 1(844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic
BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation.
0542-02 Adenosine 6mg, 2ml Vial (limited qty on hand) 0301-67 Adenosine 6mg, 2ml LL Syringe 0651-04 ADENOSINE 12MG 4ML SDV 0301-68 Adenosine 12mg, 4ml LLSyringe early early 0302-66 Amiodarone 150mg, 3ml
Our mission is better health care outcomes.
Our mission is better health care outcomes. Efficiency Purity Efficacy Product Catalog April 2019 nephronpharm.com 1(844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic
UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH
Page 1 of 8 ADMINISTRATION OF MEDICATION BY IV PUSH AUDIENCE POLICY This document is directed to Registered Nurses (RNs), Licensed Vocational Nurses (LVN s), and physicians. The following delineates the
Medications and IV Fluids List
Face The Challenge, Inc. 16748 E. Smoky Hill Rd., Box 300 Centennial, CO 80015-2495 USA tel: 303.699.7970 fax: 303.699.7454 www.facethechallenge.org Surgically Correcting Facial Deformities of the World
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA
Introduction to Antineoplastic Prescribing
Introduction to Antineoplastic Prescribing Robert Bradbury, R.Ph., BCPS Clinical Coordinator H. Lee Moffitt Cancer Center Objectives Meet the following goals concerning antineoplastic prescribing: Understand
IV Medication Drip Chart
IV Medication Drip Chart Index Summary chart 2 IV Medication drip chart Amiodarone 2 Atracurium 2, 5 Cisatracurium 2, 5 Dexmedetomidine 2 Dobutamine 2, 6 Dopamine 2, 6 Epinephrine 2, 7 Esmolol 2, 7 Etomidate
UMC Health System Patient Label Here. PHYSICIAN ORDERS Diagnosis
PICU GENERAL PLAN UMC Health System PHYSICIAN S Diagnosis Weight Allergies Patient Care Vital Signs Per Unit Standards Daily Weight Patient Activity Bedrest Up Ad Lib/Activity as Tolerated Strict Intake
Bladder Cancer Pathways (Urothelial)
Bladder Cancer Pathways (Urothelial) Patient Name: Date of Birth: Member Number: Treatment Start Date: ICD-10 Code: Pathology: Stage: 0a 0is I II III IV Recurrent Line of Treatment: Neoadjuvant/Pre-Op
GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION
GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY More than half of all cancer patients experience nausea or vomiting during the course of their treatment. If nausea or vomiting becomes severe enough,
2019 Catalog Hospital and Ophthalmology Products and Services
209 Catalog Hospital and Ophthalmology Products and Services Ophthalmology Ophthalmology Services. No prescription required No minimum order quantity New formulations are continually added to our portfolio.
COST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!!
UICCEMLCostingScenarios BackoftheEnvelope Calculations PreparedforWorkingGroupSession:19621November2014,Geneva MethodsSummary We have chosen a conservative approach, calculating cost per vial. We have
Release of the 2017/18 Invitation to Tender
2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s
PHYSICIAN ORDERS Diagnosis
PICU PROCEDURE PLAN PHYSICIAN S Diagnosis Weight Allergies DETAILS Admit/Discharge/Transfer Patient Status Pt Status: Inpatient (LOS > 2 midnights) Pt Status: Observation (LOS < 2 midnights) Patient Care
BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation.
September 28, 2018 Pharmaceutical Backorder Report BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description 0542-02 Adenosine 6mg, 2ml Vial (limited
West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting
West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting Definitions Acute nausea and vomiting Delayed nausea and vomiting Anticipatory nausea and vomiting Initial
The following are J Code requirements
The following are J Code requirements J Codes 20610 Arthrocentesis, aspiration and/or injection; major joint or bursa (eg, shoulder, hip, knee joint, subacromial bursa) A9579 Injection, gadolinium based
Bladder Cancer (Urothelial) Pathways
Bladder Cancer (Urothelial) Pathways Patient Name: Date of Birth: Member Number: Treatment Start Date: ICD-10 Code: Pathology: Stage: 0a 0is I II III IV Recurrent Line of Treatment: Neoadjuvant/Pre-Op
1 17 ACITRETIN 10MG CAP 20, ,000 14,000 4, ACITRETIN 25MG CAP 50, ,000 35,000 10,000
ردیف کد ژنریک نام ژنریک مبلغ پوشش وزارت بهداشت مبلغ پوشش بیمه مبلغ پرداخت بیمار درصد پرداخت بیمار قیمت اعالمی وزارت بهداشت نام تجاری 1 17 ACITRETIN 10MG CAP 20,000 10.0 2,000 14,000 4,000 2 18 ACITRETIN
FOR A HIGHER DEGREE OF CONFIDENCE
SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS. > Introduction Manufacturing specialized products in a pharmaceutical manufacturing environment has a specific set of requirements
Math for Meds. College of Southern Nevada. Practice Problems. Nursing 211
Math for Meds College of Southern Nevada Nursing 211 Name: Date: Directions: 1. Solve the dosage calculation problems utilizing the method of your choice. 2. Show your work! 3.Divide math out to the thousandth
High Alert Medications
High Alert Medications The following medications have been identified as High Alert Medications. Special precautions must be taken in the receipt, storage, distribution and administration of these drugs.
SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS
SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS Manufacturing specialized products in a pharmaceutical
Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved
Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole
Release of the 2014/15 Invitation to Tender
6 November 2014 Release of the 2014/15 Invitation to Tender The 2014/15 Invitation to Tender (2014/15 ITT) has been distributed today. Please note that the Electronic Portal will not be available until
Exhibit B United States Patent Application 20020012663 Kind Code A1 Waksal, Harlan W. January 31, 2002 Treatment of refractory human tumors with epidermal growth factor receptor antagonists Abstract A
Average of qty_parlvl rx_disp BIE_OR BIE_ORCOR2 BIE_PACU BIS_OR BIS_PACU BIW_OR BIW_ORCOR2 BIW_PACU Grand Total AA Open Fridge AA Used
Average of qty_parlvl omni_stid rx_disp BIE_OR BIE_ORCOR2 BIE_PACU BIS_OR BIS_PACU BIW_OR BIW_ORCOR2 BIW_PACU Grand Total AA Open Fridge 0 0 0 0 0 0 AA Used Kits Door 1 0 5000 2500 AA Used Kits Door 4
OFFERâ S INJECTABLES
A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary
Procedure. AREAS OF RESPONSIBILITY All UNMH staff.
Page 1 of 8 Title: High Alert, and Look-Alike Sound-Alike Medications Applies To: UNM Hospitals Responsible Department: Pharmacy Procedure Patient Age Group: ( ) N/A (X) All Ages ( )Newborns ( )Pediatric
Zzbeacon,Zayna [MR ]
![Zzbeacon,Zayna [MR ]](/thumbs/86/93872827.jpg "Zzbeacon,Zayna [MR ]")
AALL1131 INTERIM MAINTENANCE, HR-ALL, ARM B, HD MTX Properties Cycle 1 9/27/2012 through 11/28/2012 (63 days), Planned Day 1, Cycle 1 Planned for 9/27/2012 Release CBC and differential Release Release
6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center
RATE Abciximab (Reopro) Alteplase (tpa, Activase) All units 6S and 6W ONLY Platelet aggregation inhibitor Thrombolytic agent Bolus: 0.25 mg/kg IV over 5 min Infusion: 0.125 0.9 mg/kg (max 90 mg); 10% of
ANESTHESIA DRUG REVIEW
ANESTHESIA REVIEW CAPA S 39 TH ANNUAL CONFERENCE PALM SPRINGS OCTOBER 10, 2015 ROBERT F. KOPEL, MD, FACP, FCCP HOAG HOSPITAL CARDIAC ANESTHESIOLOGIST ASSISTANT CLINICAL PROFESSOR UCLA SCHOOL OF MEDICINE
UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE
UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE Subject: Hazardous Drugs and Chemicals IAC.657-7.8(10) (Formerly High Alert and Hazardous Medications MM.01.01.03) (Formerly
MASCC Guidelines for Antiemetic control: An update
MASCC / ISOO 17 th International Symposium Supportive Care in Cancer June 30 July 2, 2005 / Geneva, Switzerland MASCC Guidelines for Antiemetic control: An update Sussanne Börjeson, RN, PhD Linköping University,
Davis s Drug Guide Scavenger Hunt 15 th Edition
Davis s Drug Guide Scavenger Hunt 15 th Edition This handout is designed to assist you in locating information in the Davis s Drug Guide. Take advantage of the many resources in this text!! Locate the
2. Date of most recent breast cancer diagnosis / / 3. Pathlogy: Padget s Phyllodes Tubular Medullary Mucinous
Breast Cancer Patients: Begin on page 1, then skip to page 3 Lymphoma Patients: Begin on page 2 1. Newly diagnosed with Breast carcinoma Stage: (includes inflammatory breast and newly diagnosed recurrent
AMMONIA AROMATIC 15 % (W/V) SOLUTION FOR
NDC Code HCPCS Code Medication Name & Amount Inpatient Fee 00904525646 J8499 ACETAMINOPHEN 80 MG CHEWABLE TABLET 1.00 00904198261 J3490 ACETAMINOPHEN 325 MG TABLET 1.00 50580050110 J3490 ACETAMINOPHEN
ADENOSINE (Adenocard) VO = Intermediate Paramedic. ALBUTEROL SULFATE VO = EMT, EMT-IV, Intermediate Paramedic
ADENOSINE (Adenocard) ALBUTEROL SULFATE VO = EMT,, AMIODARONE (Cordarone) -except in cardiac arrest ASPIRIN EMT, ATROPINE SULFATE -except in cardiac arrest 1 ST dose 6 mg IVP, 2 ND dose 12 mg IVP, 3 rd
VUMC INTRAVENOUS MEDICATION ADMINISTRATION CHART Approved by Pharmacy, Therapeutics, and Diagnostics Committee, Last Revised August 2018
* Refer to references such as Mosby s for additional information on administration and monitoring. Alternate infusion rates permitted at provider discretion. ** Central Line Preferred indicates that the
PICU BRONCHIOLITIS PLAN
PICU BRONCHIOLITIS PLAN Diagnosis Weight PHYSICIAN S Allergies Admit/Discharge/Transfer Patient Status Pt Status: Inpatient (LOS > 2 midnights) Pt Status: Observation (LOS < 2 midnights) Patient Care Code
San Juan Islands EMS Meeting October 1, :00pm 1:00pm Zoom:
San Juan Islands EMS Meeting October 1, 2018 12:00pm 1:00pm Zoom: https://uw-phi.zoom.us/j/2065208962 INTRODUCTIONS: Dr. Pete McGough, Dr. Matt Jaffy, Dr. Mike Alperin, Dr. Mike Sullivan, Darren Layman,
Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site
Supplementary Table 1. ICD-9-CM codes used to define cancer ICD-9 Diagnosis code 140.xx-172.xx 174.xx-195.xx 196.xx 198.xx 199.xx 200.xx-208.xx Description Primary malignant neoplasms, not lymphatic or
Drug Dosage Practice Problems
Drug Dosage Practice Problems Topics covered: Metric Conversions -------------------------------------------------------------- page 2 General Conversions ------------------------------------------------------------
Chemotherapy 101 for Radiation Oncology Workers
Chemotherapy 101 for Radiation Oncology Workers James Sinclair, M.D. CCARE/Medical Director Scripps Cancer Center March 9, 2013 Category 1) Alkylating agents Alkylating agents directly damage DNA to prevent
MEDICATION USE POLICY TITLE: STANDARD CONCENTRATION AND ADMIXTURE POLICY OF IV DRIPS (ADULT) EFFECTIVE DATE: 11/2005 POLICY #: PN.
TITLE: STANDARD CONCENTRATION AND ADMIXTURE POLICY OF IV DRIPS (ADULT) EFFECTIVE DATE: 11/2005 POLICY #: PN.03 PAGE: 1 CREATED BY: R. Thelin, PharmD, A. Savite, RN Review/Revision: 3/07, 10/07, 7/09, 7/10,
Guidelines for the Use of Anti-Emetics with Chemotherapy
Guidelines for the Use of Anti-Emetics with The purpose of this document is to provide guidance on the rational use of anti-emetics for prevention and treatment of chemotherapy-induced nausea and vomiting
Section 8.4 Special Dilutions
Section 8.4 Special Dilutions Terminology: Diluent: Pediatric Compound Sterile Preparations (CSPs): Special Dilutions: Calculating Special Dilutions: Ratio-Proportion vs Dimensional Analysis Part A Calculating
HIGH ALERT MEDICATIONS
PAGE: 1 of 12 1. PURPOSE This policy describes minimum standards to assure that sites, departments, and areas in Aurora Health Care that handle high risk medications have considered the risk of error associated
Look Alike & Sound Alike Drugs
Look Alike & Sound Alike Drugs To prevent medication errors involving drugs that may look alike or sound alike, consider the following practices: Medication Ordering Distinguishing Medications By: Medication
Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)
Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates April 2018 TRADE NAME (generic name) or generic name Brand/Generic Description of Change abacavir sulfate soln 20 mg/ml (base equiv) Generic
methylergonovine 0.2 mg/ml (1 ml) injection solution enoxaparin 100 mg/ml subcutaneous syringe
Px Code Generic Name NDC Unit Price 2580001 phenylephrine 1 mg/10 ml (100 mcg/ml) in 0.9 % sod.chloride IV syringe 69374095710 136.29 2580001 phenylephrine 1 mg/10 ml (100 mcg/ml) in 0.9 % sod.chloride
VIVA Health, Inc. Part D Cumulative Formulary Changes for 2009
ulary ulary Effective ADDS 00472088282 ACETASOL HC 2%; 1% SOLN Pref(1) no 1/29/2009 3/1/2009 68382026101 ACETAZOLAMIDE 500MG CP12 Pref(1) yes 3/24/2009 5/1/2009 00078056651 AFINITOR 5MG TABS Pref (4);
J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364
G0333 INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.470 J0285 INJECTION, AMPHOTERICIN B 50 MG $10.280 J0287 INJECTION, AMPHOTERICIN B LIPID COMPLEX 10 MG $21.850 J0288
Emetogenicity level 1. Emetogenicity level 2
Emetogenicity level 1 15 mins Pre-Chemo Maxalon 10mg po During chemo and Post Chemo 3 days Maxalon10mg po 8 hourly Increase Maxalon 20mg po 8 hourly Change to Cyclizine 50mg po 8 hourly 3 days If nausea
Hodgkin and Non-Hodgkin Lymphoma (LYM) Post-Infusion Data
Hodgkin and Non-Hodgkin Lymphoma (LYM) Post-Infusion Data Registry Use Only Sequence Number: Date Received: CIBMTR Center Number: CIBMTR Research ID: Event date: / / Visit 100 day 6 months 1 year 2 years
OPEN AAA/MAJOR ABDOMINAL POST-OP PLAN - Phase:.
- Phase:. PHYSICIAN S Diagnosis Weight Allergies Patient Care Vital Signs Per Unit Standards Maintain Gastric Tube Maintain Nasogastric - NG, Low Intermittent Suction Maintain Nasogastric - NG, Low Constant
ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY
ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY Problem Opening PACS Images on ipads or ibooks has Been Fixed Changes have been made in PROD to enable user credentials to be passed
Blanchard Valley Hospital Pharmacy Code Blue Overview
Blanchard Valley Hospital Pharmacy Code Blue Overview Adapted from Gary Spanik, RPh Edited by Kate Reeves, Pharm D, RPh Jon Manocchio, Pharm D, RPh Pharmacist Responsibilities Be aware of basic ACLS tenets
PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG
DRUG AND TREATMENT Pre-Procedure Diet NPO NPO except for meds with sip of water, Give all medications as scheduled except diabetic medications. Nursing Orders Start IV/INT Start IV/INT To use as a dedicated
SREMS Minimum Equipment Standards
Ambulance AEMT EMT-CC EMT-P Standard Description Opt Req Opt Req Opt Req Opt Req Unit meets NYS minimum BLS equipment standards for X certification, per latest Part 800. Portable monitor-defibrillator
Medications currently available to treat Multiple Myeloma include: Current Code Price (AWP) Effective Date. Code Price (AWP)
drug and administration compendia Compendia information developed and maintained by With each publication Managed Care Oncology s Drug & Compendia will highlight a single medication or a group of medications
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Lynparza) Reference Number: CP.PHAR.360 Effective Date: 10.03.17 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this
Guideline Update on Antiemetics
Guideline Update on Antiemetics Clinical Practice Guideline Special Announcements Please check www.asco.org/guidelines/antiemetics for current FDA alert(s) and safety announcement(s) on antiemetics 2 Introduction
PICU TRAUMA PLAN - Phase:.
- Phase:. UMC Health System PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care CR Monitoring Vital Signs Per Unit Standards Daily Weight Perform Neurological Checks q15min q30min q1h Special Instructions,
PEDIATRIC PICU TRAUMA PLAN EKM - Phase: PICU Trauma Plan
- Phase: PICU Trauma Plan Diagnosis Weight Allergies DETAILS Patient Care Vital Signs Per Unit Standards Daily Weight Perform Neurological Checks q15min q30min q1h Special Instructions, with Vital Signs
Chemotherapy Agents 101
Chemotherapy Agents 101 Jumana Ashy, Pharm D, BCOP Judith Misas, PharmD Candidate 2018 Jeremy Hutchinson, PharmD Sady Castance, PharmD September 12, 2017 1 Learning Objectives At the end of the presentation
Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted.
Patient Name: Diagnosis: Allergies with reaction type: Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted. Telemetry Medical Telemetry:
Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients
Guidelines on Chemotherapy-induced Nausea Vomiting in Pediatric Cancer Patients COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For
Adjuvant Systemic Therapy in Early Stage Breast Cancer
Adjuvant Systemic Therapy in Early Stage Breast Cancer Julie R. Gralow, M.D. Director, Breast Medical Oncology Jill Bennett Endowed Professor of Breast Cancer Professor, Global Health University of Washington
BlueLink TPA FlexRx Updates
BlueLink TPA FlexRx Updates April 2018 TRADE NAME (generic name) or generic name abacavir sulfate soln 20 mg/ml (base equiv) Generic Addition, generic for ZIAGEN alclometasone dipropionate cream 0.05%
Texas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
INPATIENT INTERVENTIONAL RADIOLOGY PLAN - Phase: Pre-Procedure Orders
- Phase: Pre-Procedure Orders DETAILS Patient Care Obtain Consent If one is not present on chart today. Vital Signs Per Policy Insert Peripheral Line T;N, Start IV on right side If left radial access is
PDP Classic Formulary Addendum
PDP Classic Formulary Addendum The following medications have been added to the WellCare formulary as of March 2009. Drug Name Therapeutic Class Drug Tier Requirements/Limits Changes Made acetazolamide
NOTICES DEPARTMENT OF HEALTH
NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [42 Pa.B. 4229] [Saturday, July 7, 2012] Under 28 Pa. Code 1005.11(b) (relating to drug use, control and security), the following
Vasco OP Underglove Sterile Surgical and Protective Gloves
data sheet EN 374:2003 EN 374:2003 AQL 0.65 B. Braun Melsungen AG confirms that Vasco OP Underglove gloves comply with the following standards and directives: EC CERTIFICATES AND Applied standards Medical
DRUG ALLERGIES WT: KG
DRUG AND TREATMENT Acute Diabetic Ketoacidosis Condition/Status ***(NOTE)*** For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS
Part B payment for drugs in Medicare 0
Part B payment for drugs in Medicare 0 Introduction: The recent pilot proposal 1 on Part B drug payment from the Center for Medicare and Medicaid Innovation of CMS has met strong resistance 2 from the